Flagship Biosciences
The AI engine Fit Assessment
BetaFlagship Biosciences leverages machine learning for data analysis, discovers new patterns in biomarker data, and supports drug development, enhancing therapeutic options.
Blurb
Flagship Biosciences delivers comprehensive tissue profiling using our Artificial Intelligence (AI) enabled cTA® pathology platform.
HQ Location
Westminster (United States)
Founded
2009
Employees
51 - 200
Total funding raised
$20.29M
Last Funding Event
Venture - Series Unknown, $5.00M, April 16, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Biomarker Identification
Flagship Biosciences delivers comprehensive tissue profiling for predictive diagnostic applications using our Artificial Intelligence (AI) enabled cTA® pathology platform. Our intuitive data reporting gives researchers, clinicians, and drug developers the actionable information needed to drive better clinical results for patients.